Similarly, NK-mediated lysis of tumor cells is enhanced after DNAM-1 (in NK cells) interacts with PVR or Nectin-2 (in target cells), whereas this effect is inhibited by treatment with a mAb targeting DNAM-1 or its receptor [15]. Here, PVR is linked to neoplasm.